Credit Suisse CEO to step down from embattled investment bank, WSJ says

Credit Suisse CEO to step down from embattled investment bank, WSJ says


Credit Suisse Chief Executive Thomas Gottstein addresses the Finanz und Wirtschaft Forum conference in Zurich, Switzerland, September 2, 2020.

Arnd Wiegmann | Reuters

Credit Suisse CEO Thomas Gottstein is about to step down from the embattled investment bank, the Wall Street Journal reported on Tuesday.

The Zurich-based bank will soon announce the departure of Gottstein after a tenure that included a series of embarrassing mishaps and several unprofitable quarters, according to the Journal. His replacement couldn’t be determined, the newspaper said.

Candice Sun, a spokesperson for the bank, declined to comment on the report.

Credit Suisse is set to report second-quarter results on Wednesday, and it has already warned investors that it will lose money. The bank blamed worsening economic conditions in Europe and Asia for the loss.

Gottstein, a two-decade veteran of Credit Suisse, took over in early 2020 from predecessor Tidjane Thiam, who resigned after a spying scandal. Gottstein was soon wrestling with the costly fallout from the meltdown of two key clients: the Archegos family office and supply-chain finance firm Greensill.

Investors have been calling for change atop Credit Suisse amid the risk management failures and a sagging stock : Shares of the bank are down 46% this year.

That’s considerably worse than the 21% decline of the U.S.-centric KBW Bank Index; American banks reported mixed second-quarter results earlier this month, with sharp declines in investment-banking revenue, but all six of the biggest U.S. banks had profitable quarters.



Source

Stocks making the biggest moves midday: Nvidia, Ultragenyx Pharmaceutical, Newmont, DigitalBridge & more
Finance

Stocks making the biggest moves midday: Nvidia, Ultragenyx Pharmaceutical, Newmont, DigitalBridge & more

Check out some of the stocks making the biggest moves in midday trading. Ultragenyx Pharmaceutical – Shares cratered more than 40% after Ultragenyx announced that its bone disease drug setrusumab fell short of expectations in two trials. “Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo or bisphosphonates,” […]

Read More
Silver tops  for first time, then stages dramatic reversal overnight
Finance

Silver tops $80 for first time, then stages dramatic reversal overnight

Key Points Silver slid more than 3% on Monday, after topping $80 for the first time ever in overnight trading. The precious metal was still higher by more than 155% year to date. It started 2025 trading above just $20 per ounce. That has helped the precious metal outperform even gold this year. Source

Read More
Stocks making the biggest moves premarket: DigitalBridge, Praxis Precision Medicines, Coupang & more
Finance

Stocks making the biggest moves premarket: DigitalBridge, Praxis Precision Medicines, Coupang & more

Check out the companies making headlines before the bell: DigitalBridge — The private equity firm that invests in data centers and other assets surged more than 32% after Bloomberg News, citing unnamed sources, said Japan’s SoftBank is in advanced talks to acquire DigitalBridge. The deal could be announced as soon as Monday, Bloomberg reported. Nvidia […]

Read More